HIF-2 Pseudoinhibitor Generic Drug for RCC

Belzutifan, by the way, is this thing called a HIF-2 pseudoinhibitor. It’s mostly used to treat this cancer called VHL-associated renal cell carcinoma. The way it works is by cutting down on that tumor hypoxia signaling.

It comes in these 40 mg film-coated tablet things. Doctors usually suggest taking 120 mg of it every day. You can get it in bottles that hold about 90 tabs.

Just so you know, each tablet’s dose is planned to add up to the full 120 mg you’re meant to take each day.